VISINE L.R. Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Visine L.r., and when can generic versions of Visine L.r. launch?
Visine L.r. is a drug marketed by Johnson And Johnson and is included in one NDA.
The generic ingredient in VISINE L.R. is oxymetazoline hydrochloride. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for VISINE L.R.?
- What are the global sales for VISINE L.R.?
- What is Average Wholesale Price for VISINE L.R.?
Summary for VISINE L.R.
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 67 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,937 |
| DailyMed Link: | VISINE L.R. at DailyMed |
Recent Clinical Trials for VISINE L.R.
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Massachusetts Eye and Ear Infirmary | Phase 2 |
US Patents and Regulatory Information for VISINE L.R.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Johnson And Johnson | VISINE L.R. | oxymetazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 019407-001 | Mar 31, 1989 | OTC | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
